Correction: Biomarkers of inflammation, immunosuppression and stress are revealed by metabolomic profiling of tuberculosis patients (PLoS ONE(2016)7:7(e40221)Doi: 10.1371/journal.pone.0040221);Biomarkers of inflammation, immunosuppression and stress with active disease are revealed by metabolomic profiling of tuberculosis patients

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Weiner, January ^a   Parida, Shreemanta K ^a,e   Maertzdorf, Jeroen ^a   Black, Gillian F ^b,f   Repsilber, Dirk ^c   Telaar, Anna ^c   Mohney, Robert P ^d   Arndt Sullivan, Cordelia ^a,g   Ganoza, Christian A ^a   Faé, Kellen C ^a   Walzl, Gerhard ^b   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c LEIBNIZ INSTITUTE FOR FARM ANIMAL BIOLOGY FBN   (Germany)

^d METABOLON INC   (United States)

^e DEPARTMENT OF BIOTECHNOLOGY   (India)

^f Sustainable Livelihoods Foundation   (South Africa)

^g HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ALKALINE PHOSPHATASE; ALPHA2 INTERFERON; BIOLOGICAL MARKER; CD135 ANTIGEN; EOTAXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INDOLEAMINE 2,3 DIOXYGENASE; INDOLEAMINE 2,3 DIOXYGENASE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; KYNURENINE; MACROPHAGE DERIVED CHEMOKINE; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; PHOSPHOLIPASE; TRYPTOPHAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RESPONSE; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENZYMATIC DEGRADATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LIPID METABOLISM; LYMPHOCYTE PROLIFERATION; MACROPHAGE; METABOLITE; METABOLOME; METABOLOMICS; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUBERCULOSIS; UPREGULATION;

EID: 84864612118     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153050     Document Type: Erratum

References (75)

1. Illig T, Gieger C, Zhai G, Römisch-Margl W, Wang-Sattler R, et al. (2009) A genome-wide perspective of genetic variation in human metabolism. Nat Genet 42: 137-141.
2. Kaddurah-Daouk R, Kristal BS, Weinshilboum RM, (2008) Metabolomics: a global biochemical approach to drug response and disease. Pharmacol Toxicol 48: 653-683.
3. Han X, Holtzman M, McKeel DW Jr, Kelley J, Morris JC, (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis. J Neurochem 82: 809-818. 0997 [pii].
4. Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, et al. (2008) Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131: 389-396.
5. Sabatine MS, Liu E, Morrow DA, Heller E, McCarroll R, et al. (2005) Metabolomic identification of novel biomarkers of myocardial ischemia. Circulation 112: 3868-3875.
6. Brindle JT, Nicholson JK, Schofield PM, Grainger DJ, Holmes E, (2003) Application of chemometrics to 1 H NMR spectroscopic data to investigate a relationship between human serum metabolic profiles and hypertension. Analyst 128: 32-36.
7. Yang J, Xu G, Zheng Y, Kong H, Pang T, et al. (2004) Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases. J Chromatogr B 813: 59-65.
8. Wang C, Kong H, Guan Y, Yang J, Gu J, et al. (2005) Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem 77: 4108-4116.
9. Yuan K, Kong H, Guan Y, Yang J, Xu G, (2007) A GC-based metabonomics investigation of type 2 diabetes by organic acids metabolic profile. J Chromatogr B 850: 236-240.
10. Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, et al. (2007) A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiological genomics 29: 99-108.
11. Suhre K, Wallaschofski H, Raffler J, Friedrich N, Haring R, et al. (2011) A genome-wide association study of metabolic traits in human urine. Nat Genet 43: 565-569.
12. Laiakis EC, Morris GAJ, Fornace AJ, Howie SRC, (2010) Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study. PloS one 5: e12655.
13. Wang Y, Utzinger J, Saric J, Li JV, Burckhardt J, et al. (2008) Global metabolic responses of mice to Trypanosoma brucei brucei infection. Proc Natl Acad Sci USA 105: 6127-6132.
14. Slupsky CM, Rankin KN, Fu H, Chang D, Rowe BH, et al. (2009) Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. J Proteome Res 8: 5550-5558.
15. Somashekar BS, Amin AG, Rithner CD, Troudt JL, Basaraba R, et al. (2011) Metabolic profiling of lung granuloma in Mycobacterium tuberculosis infected guinea pigs: ex vivo 1 H magic angle spinning NMR studies. J Proteome Res 10: 4186-4195.
16. Shin JH, Yang JY, Jeon BY, Yoon YJ, Cho SN, et al. (2011) 1H-NMR-based metabolomic profiling in mice infected with Mycobacterium tuberculosis. J Proteome Res 10: 2238-2247.
17. Lawn SD, Zumla AI, (2011) Tuberculosis. Lancet 378: 57-72.
18. Philips JA, Ernst JD, (2012) Tuberculosis Pathogenesis and Immunity. Ann Rev Pathol Mech Dis 7: 353-384.
19. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, et al. (2010) Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 375: 1814-1829.
20. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, et al. (2007) Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 85: 613-621.
21. Berry MPR, Graham CM, McNab FW, Xu Z, Bloch SAA, et al. (2010) An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466: 973-977.
22. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, et al. (2011) Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 12: 15-22.
23. Breiman L, (2001) Random forests. Mach Learn 45: 5-32.
24. Lê Cao K-A, González I, Déjean S, (2009) integrOmics: an R package to unravel relationships between two omics datasets. Bioinformatics 25: 2855.
25. Mellor AL, Munn DH, (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nature Rev Immunol 4: 762-774.
26. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, et al. (1998) Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191.
27. Munn DH, Sharma MD, Hou D, Baban B, Lee JR, et al. (2004) Expression of indoleamine 2, 3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114: 280-290.
28. Katz JB, Muller AJ, Prendergast GC, (2008) Indoleamine 2, 3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 222: 206-221.
29. Popov A, Abdullah Z, Wickenhauser C, Saric T, Driesen J, et al. (2006) Indoleamine 2, 3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest 116: 3160.
30. Boasso A, Herbeuval JP, Hardy AW, Anderson SA, Dolan MJ, et al. (2007) HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2, 3-dioxygenase in plasmacytoid dendritic cells. Blood 109: 3351.
31. Romani L, Fallarino F, De Luca A, Montagnoli C, D'Angelo C, et al. (2008) Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 451: 211-215.
32. Favre D, Mold J, Hunt PW, Kanwar B, Loke P, et al. (2010) Tryptophan catabolism by indoleamine 2, 3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease. Science Trans Med 2: 32ra36.
33. Makala LHC, Baban B, Lemos H, El-Awady AR, Chandler PR, et al. (2011) Leishmania major attenuates host immunity by stimulating local indoleamine 2, 3-dioxygenase expression. J Infect Dis 203: 715.
34. Platten M, Ho PP, Youssef S, Fontoura P, Garren H, et al. (2005) Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310: 850.
35. Sharma MD, Hou DY, Liu Y, Koni PA, Metz R, et al. (2009) Indoleamine 2, 3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 113: 6102.
36. Sharma MD, Hou DY, Baban B, Koni PA, He Y, et al. (2010) Reprogrammed Foxp3+ regulatory T cells provide essential help to support cross-presentation and CD8+ T cell priming in naive mice. Immunity 33: 942-954.
37. Müller A, Heseler K, Schmidt SK, Spekker K, MacKenzie CR, et al. (2009) The missing link between indoleamine 2, 3-dioxygenase mediated antibacterial and immunoregulatory effects. J Cell Mol Med 13: 1125-1135.
38. Grohmann U, Volpi C, Fallarino F, Bozza S, Bianchi R, et al. (2007) Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nature Med 13: 579-586.
39. Suzuki Y, Suda T, Asada K, Miwa S, Suzuki M, et al. (2012) Serum indoleamine 2, 3-dioxygenase activity predicts prognosis of pulmonary tuberculosis. Clinical and Vaccine Immunology.
40. Mehta D, Gupta S, Gaur SN, Gangal SV, Agrawal KP, (1990) Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine. Am Rev Resp Dis 142: 157-161.
41. Okita M, Gaudette DC, Mills GB, Holub BJ, (1997) Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine(lysoPC) in ovarian cancer patients. Int J Cancer 71: 31-34.
42. Taylor L, Arends J, Hodina A, Unger C, Massing U, (2007) Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status. Lipids Health Dis 6: 17.
43. Drobnik W, Liebisch G, Audebert FX, Frohlich D, Gluck T, et al. (2003) Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. J Lipid Res 44: 754-761.
44. Duan L, Gan H, Arm J, Remold HG, (2001) Cytosolic Phospholipase A2 Participates with TNF-{{alpha}} in the Induction of Apoptosis of Human Macrophages Infected with Mycobacterium tuberculosis H37Ra. J Immunol 166: 7469-7476.
45. Lewis GD, Wei RU, Liu E, Yang E, Shi X, et al. (2008) Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 118: 3503.
46. Bell MJ, Kochanek PM, Carcillo JA, Mi Z, Schiding JK, et al. (1998) Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J Neurotraum 15: 163-170.
47. Jin X, Shepherd RK, Duling BR, Linden J, (1997) Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 100: 2849-2857.
48. Gomez G, Sitkovsky MV, (2003) Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 102: 4472-4478.
49. Den Boon S, Van Lill SWP, Borgdorff MW, Verver S, Bateman ED, et al. (2005) Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax 60: 555-557.
50. Dever JT, Elfarra AA, (2006) In Vivo Metabolism of l-Methionine in Mice: Evidence for Stereoselective Formation of Methionine-d-Sulfoxide and Quantitation of Other Major Metabolites. Drug Metab Dispos 34: 2036-2043.
51. Avila MA, Carretero MV, Rodriguez EN, Mato JM, (1998) Regulation by hypoxia of methionine adenosyltransferase activity and gene expression in rat hepatocytes. Gastroenterology 114: 364-371.
52. Kono H, Enomoto N, Connor HD, Wheeler MD, Bradford BU, et al. (2000) Medium-chain triglycerides inhibit free radical formation and TNF-alpha production in rats given enteral ethanol. Am J Physiol Gastrointest Liver Physiol 278: G467-G476.
53. Harrison RA, Farries TC, Northrop FD, Lachmann PJ, Davis AE, (1988) Structure of C3f, a small peptide specifically released during inactivation of the third component of complement. Complement 5: 27-32.
54. Sakamoto M, Fujisawa Y, Nishioka K, (1998) Physiologic role of the complement system in host defense, disease, and malnutrition. Nutrition 14: 391-398.
55. Szeplaki G, Prohaszka Z, Duba J, Rugonfalvi-Kiss S, Karadi I, et al. (2004) Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis 177: 383-389. S0021-9150(04)00394-6 [pii];10.1016/j.atherosclerosis.2004.07.022 [doi].
56. Chan TYK, (2000) Vitamin D Deficiency and Susceptibility to Tuberculosis. Calcified Tissue Int 66: 476-478.
57. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770.
58. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, et al. (2000) Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 355: 618-621.
59. Ustianowski A, Shaffer R, Collin S, Wilkinson RJ, Davidson RN, (2005) Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London. J Infection 50: 432-437.
60. Cohen G, Rudnicki M, Hoorl WH, (2001) Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils. Kidney Int 59: S48-S52.
61. Hutchings A, van Staden J, (1994) Plants used for stress-related ailments in traditional Zulu, Xhosa and Sotho medicine. Part 1: Plants used for headaches. J Ethnopharmacol 43: 89-124. 0378-8741(94)90008-6 [pii].
62. Chang WK, Yang KD, Shaio MF, (1999) Lymphocyte proliferation modulated by glutamine: involved in the endogenous redox reaction. Clin Exp Immunol 117: 482-488.
63. Parry-Billings M, Calder PC, Newsholme EA, Evans J, (1990) Does glutamine contribute to immunosuppression after major burns? Lancet 336: 523-525.
64. Kinscherf R, Hack V, Fischbach T, Friedmann B, Weiss C, et al. (1996) Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetyl-cysteine. J Mol Med 74: 393-400.
65. Huettmann A, Duehrsen U, Stypmann J, Noppeney R, Nueckel H, et al. (2006) Granulocyte colony-stimulating factor-induced blood stem cell mobilisation in patients with chronic heart failure. Basic Res Cardiol 101: 78-86.
66. To LB, Haylock DN, Simmons PJ, Juttner CA, (1997) The biology and clinical uses of blood stem cells. Blood 89: 2233.
67. Schwenk A, Macallan DC, (2000) Tuberculosis, malnutrition and wasting. Curr Opin Clin Nutr Metab Care 3: 285.
68. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E, (2009) Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 81: 6656-6667.
69. Sha W, da Costa KA, Fischer LM, Milburn MV, Lawton KA, et al. (2010) Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline. FASEB J 24: 2962-2975.
70. DeHaven C, Evans A, Dai H, Lawton K, (2010) Organization of GC/MS and LC/MS metabolomics data into chemical libraries. Journal of cheminformatics 2: 9.
71. Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, et al. (2003) Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4: 1206-1212.
72. Smyth GK, (2005) Limma: linear models for microarray data. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York: Springer. pp. 397-420.
73. Benjamini Y, Hochberg Y, (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B Met 57: 289-300.
74. Liaw A, Wiener M, (2002) Classification and Regression by randomForest. R news 2: 18-22.
75. Suzuki R, Shimodaira H, (2006) Pvclust: an R package for assessing the uncertainty in hierarchical clustering. Bioinformatics 22: 1540-1542.